Survey of Non-Variceal Upper Gastro Intestinal Bleeding in Vietnamese Patients
NCT ID: NCT01292915
Last Updated: 2014-05-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1044 participants
OBSERVATIONAL
2011-10-31
2013-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Factors Predicting the Need for Endoscopic Intervention in Non-variceal Upper Gastrointestinal Bleeding
NCT05979025
Endoscopic Diagnosis and Treatment of Acute Nonvariceal Upper Gastrointestinal Bleeding
NCT04895904
Study of Patients With Drug-induced Non-variceal Upper Gastrointestinal Bleeding
NCT06945328
European Survey of Non-Variceal Upper Gastro Intestinal Bleeding (NVUGIB)
NCT00797641
Assessment of Laboratory Parameters and Imaging Findings in Patients With Gastrointestinal Bleeding
NCT07002359
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Evidence that an upper GI endoscopy was performed
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dao Van Long, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
Hanoi Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Da Nang, , Vietnam
Research Site
Hanoi, , Vietnam
Research Site
HoChiMinh City, , Vietnam
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
CSR\_Synopsis\_NIS-GVN-DUM-2010\_1
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-GVN-DUM-2010/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.